Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Needham Maintains Buy on AtriCure, Raises Price Target to $92

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $90 to $92.
byBenzinga Newsdesk
November 4, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $90 to $92.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0